A systematic review of the effects of modifiable risk factor interventions on the progression of multiple sclerosis

Multiple Sclerosis

Volumn 23, Issue 4, 2017, Pages 513-524

  Hempel, Susanne ^a   Graham, Glenn D ^b,c   Fu, Ning ^a   Estrada, Elena ^d   Chen, Annie Y ^d   Miake Lye, Isomi ^d   Miles, Jeremy N V ^a   Shanman, Roberta ^a   Shekelle, Paul G ^a,d   Beroes, Jessica M ^d   Wallin, Mitchell T ^b,e  

^a RAND CORPORATION   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

MS progression; Multiple sclerosis; Randomized controlled trial; Risk factors; Systematic review

Indexed keywords

BETA1A INTERFERON; CALCIUM; CARBOHYDRATE; COLECALCIFEROL; DOCOSAHEXAENOIC ACID; ERGOCALCIFEROL; FISH OIL; FOLIC ACID; GAMMA TOCOPHEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; RIBOFLAVIN; VITAMIN D;

AEROBIC EXERCISE; ALCOHOL CONSUMPTION; ALLERGIC REACTION; CONSTIPATION; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE SEVERITY ASSESSMENT; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPEPSIA; ERYSIPELAS; EVIDENCE BASED EMERGENCY MEDICINE; EXERCISE; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FOOD AND DRUG ADMINISTRATION; GENETIC HETEROGENEITY; HEADACHE; HUMAN; INTERVENTION STUDY; LIPID DIET; LOW DRUG DOSE; META ANALYSIS; MORBIDITY; MULTIPLE SCLEROSIS; NAUSEA; OUTCOME ASSESSMENT; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SMOKING CESSATION; STRETCHING EXERCISE; SYSTEMATIC REVIEW; TRAINING; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; DIET THERAPY; DISEASE EXACERBATION; KINESIOTHERAPY; REHABILITATION CARE; ANIMAL; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; PHYSIOLOGY;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; EXERCISE; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 85018229870     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458517690271     Document Type: Review

References (15)

1. Farinotti M, Vacchi L, Simi S, et al. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2012; 12: CD004192.
2. Faridar A, Eskandari G, Sahraian MA, et al. Vitamin D and multiple sclerosis: A critical review and recommendations on treatment. Acta Neurol Belg 2012; 112: 327-333.
3. Hempel S, Fu N, Estrada E, et al. Modifiable risk factors in the progression of multiple sclerosis: A systematic review of the epidemiology and treatment. Los Angeles, CA: Department of Veterans Affairs, Health Services Research & Development Service, 2015.
4. Higgins JPT and Green S (eds). Cochrane handbook for systematic reviews of interventions (version 5.1.0). London: The Cochrane Collaboration, 2011.
5. IntHout J, Ioannidis JP and Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 2014; 14: 25.
6. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-406.
7. Schwartz I, Sajin A, Moreh E, et al. Robot-assisted gait training in multiple sclerosis patients: A randomized trial. Mult Scler 2012; 18: 881-890.
8. Armutlu K, Karabudak R and Nurlu G. Physiotherapy approaches in the treatment of ataxic multiple sclerosis: A pilot study. Neurorehabil Neural Repair 2001; 15: 203-211.
9. Bates D, Fawcett PR, Shaw DA, et al. Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis. Br Med J 1977; 2: 932-933.
10. Harbige LS and Sharief MK. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr 2007; 98(Suppl. 1): S46-S53.
11. Burton JM, Kimball S, Vieth R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010; 74: 1852-1859.
12. Feinstein A and Dalgas U. The benefits of exercise in progressive MS: Some cautious optimism. Mult Scler 2014; 20: 269-270.
13. Sa MJ Exercise therapy and multiple sclerosis: A systematic review. J Neurol 2014; 261: 1651-1661.
14. Jagannath VA, Fedorowicz Z, Asokan GV, et al. Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev 2010; 12: CD008422.
15. Healy BC, Ali EN, Guttmann CR, et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009; 66: 858-864.